TIM-3, a promising target for cancer immunotherapy

He, Yayi, Cao, Jie, Zhao, Chao, Li, Xuefei, Zhou, Caicun, Hirsch, Fred·2018·OncoTargets and Therapy
DOI 10.2147/ott.s170385

Cited by (235)

Items 201–235 of 235

  1. Immuno-modulating Mediators of Colon Cancer as Immuno-therapeutic: Mechanism and Potential
    Chanchal Kumar, Rajat Pratap Singh, Mrigendra Kumar Dwivedi, Ajay Amit · 2021 · Springer eBooks
  2. Precision medicine in immunotherapy and lung cancer
    Montse Sánchez‐Céspedes · 2023 · Anales de la Real Academia Nacional de Farmacia
  3. The co-stimulatory activity of Tim-3 requires Akt and MAPK signaling and immune synapse recruitment
    Shunsuke Kataoka, Priyanka Manandhar, Judong Lee, Creg J. Workman, Hridesh Banerjee, Andrea L. Szymczak-Workman, Michael Kvorjak, Jason J. Lohmueller, Larry Kane · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Proliferative and quiescent human gastric cancer stem-like cells are associated with differential chemoresistance and patient mortality
    Kok Siong Ang, Hong Kai Lee, Marion Chevrier, Michelle Goh, Jingjing Ling, Vivien Koh, Hang Xu, Xiaomeng Zhang, Jia Chi Tan, Nicole Yee Shin Lee et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Combination Therapies in Solid Tumour Oncology
    Alain A. Vertès · 2020 · Elsevier eBooks
  6. Dendritic Cells and Their Roles in Anti-Tumour Immunity
    Ee Shan Pang, Christophe Macri, Timothy Patton, Mariam Bafit, Meredith A O’Keeffe · 2020 · IntechOpen eBooks
  7. Can the assessment of lymphocyte exhaustion serve as a prognostic predictor after lung cancer surgery?
    Kenji Morimoto, Yoshie Morimoto, Junji Uchino · 2020 · Translational Lung Cancer Research
  8. Immune Modulation in Interventional Oncology
    Johannes Maximilian Ludwig, Michael Cecchini, Hyun S. Kim · 2020 · Springer eBooks
  9. Estudio de las interacciones de PD-1H y sus ligandos en la respuesta inmunitaria murina = The study of the interactions between PD-1H and their putative ligands in the murine immune response
    Irene del Vigo Soto · 2021
  10. PAX5 Haploinsufficiency Induces Immune Inhibitory-Related Molecules Expressions of CD8 + T Cells in the Tumor Microenvironment
    Liang Mi, Duanhao Gong, Lei Wang, Xue Liang, jiao meng, Wei Min Huang, Jianfeng Zhou · 2021 · Research Square
  11. Expression Of TIM-3 And CEACAM-1 In Bladder Urothelial Carcinoma ( Immunohistochmical And Histopathological Study )
    Abla Sayed Mohammed, Sahar Aly Daoud, Wesam Ismail Moustafa, Osama Sayed, Badawia Bayoumi Ibrahim, Marwa Mohamed Sayed, Sarah Abdelrahman Mohammed · 2021 · Egyptian Journal of Medical Research
  12. Perspectives of Radiotherapy in Immuno-oncology Era
    Yvonne Chiung-Fang Hsu, Jason Chia‐Hsien Cheng · 2021 · Springer eBooks
  13. Relationship between serum levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule-3 and Systemic Lupus Erythematosus
    2022 · Al-Azhar University Journal of Virus Researches and Studies
  14. Targeted delivery of low-dose liposomal STING agonist to CD103+ dendritic cells in tumor immunotherapy
    Aatman S. Doshi · 2021
  15. Pan-cancer analysis to provide a reliable basis for the clinical use of TIM-3 immunosuppressants
    Bangqian Mo, Yongfeng Wang, Deming Liu, Hui Cai · 2023 · Research Square
  16. Cancer immunotherapy
    Carmen Avendaño, José Carlos Menéndez · 2023 · Elsevier eBooks
  17. Die Rolle der humanen Leukozytenantigene und weitere immunregulatorische Checkpoints
    Franziska M. Würfel · 2023 · Springer eBooks
  18. Combating Immunosuppression within Tumor Microenvironment: A Novel Approach for Drug Design
    Bhalchandra Mirlekar · 2019 · Open Access Journal of Cancer & Oncology
  19. TIM3 or HAVCR2 in Breast Cancer Instead of Suppression May Invoke Immune Action in Tumor Micro Environment
    ANUPAM BASU, ARUNITA GHOSH, Barnali Dolui, Banani Majumdar, Pallavi Krishna, Arghya Bandopadhaya · 2024 · Preprints.org
  20. Animal Models for Cancer
    Fahad N. Alonazi, Yousef MohammedRabaa Hawsawi, Helal G. Alanazi, Adel M. Alqarni, Suad A. Alghamdi, Rakan J. Alanazi · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  21. Insight on the Clinical Trials of Immunotherapy for the Treatment of Lung Cancer
    Dhruv Gupta, Vaishnavi Gadi, Saritha Rakesh Shetty · 2024 · Springer eBooks
  22. Molecular cytometry for comprehensive immune profiling
    Pratip K. Chattopadhyay · 2024 · Methods in cell biology
  23. WITHDRAWN: Next generation immune checkpoints
    Natalia Muñoz Perez, Kirsten Moziak, Allison M. Martin · 2024 · Elsevier eBooks
  24. T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia
    Fatemah Salem Basingab, Manar Bashanfer, Aisha Alrofaidi, Ahmed Barefah, Rawan Hammad, Hadil Mohammad Alahdal, Jehan Alrahimi, Kawther A. Zaher, Sabah Mohammed Hassan, Ali Hassan Algiraigri et al. · 2024 · International Journal of Molecular Sciences
  25. Patient-derived Organoids as a Tool for Advancing Precision Immuno-oncology
    Xin Yi Than, Tiffany T. Ong, Edward Kai‐Hua Chow · 2024 · World Scientific Annual Review of Cancer Immunology
  26. Biomarkers of renal transplant rejection: yesterday, today, and tomorrow
    Ranjana W. Minz, Jagdeep Singh, Deepesh Benjamin Kenwar · 2025 · Elsevier eBooks
  27. Additional file 1 of PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients
    Chen, Ming, Zhu, Jinlian, Yang, Xuedong, Yao, Jianxin, Liu, Yuqing, Liu, Qiang · 2024 · Figshare
  28. Additional file 1 of Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
    Victor Sarradin, Amélie Lusque, Thomas Filleron, Florence Dalenc, Camille Franchet · 2021 · Figshare
  29. Current Immunotherapy Management of Lung Cancer
    Samuel Romeo Obiekwe, Maici Malika Yang · 2026
  30. Étude de l’effet vaccinal d’anticorps thérapeutiques anti-CD38 et des mécanismes de tolérance contrôlant la réponse immunitaire dans des modèles précliniques
    Béré Diallo · 2019
  31. Régulation de la réaction asthmatique par des agents microbiens : quelle place pour les cellules natural killer ?
    Justine V. Devulder · 2019
  32. β‐Mannosyl Triazoles as Mimics of Galactosyl Galectin‐3 and Galectin‐9 N‐Terminal Domain Inhibitors
    Fredrik Sjövall, Ulf J. Nilsson · 2026 · ChemBioChem
  33. Cancer Immunotherapy Using Immune Checkpoint Blockade
    Lobat Tayebi, Mohsen Abdolmaleki · 2026 · Springer eBooks
  34. BindingDB Entry 50021559: Structure-Based Rational Design of Constrained Peptides as TIM-3 Inhibitors.
    BindingDB · 2025 · UC San Diego
  35. BindingDB Entry 50020219: Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia Using Pharmacophore-Based Virtual Screening.
    BindingDB · 2024 · UC San Diego